Medicus Pharma LTD (MDCX) — 13F Holders Deep Dive (Q2 2026)

MDCX ranks #7976 out of 37505 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

MDCX is a disclosed holding of Jane Street (Jane Street Group), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

24 institutions disclose a position in MDCX, but none treat it as a major bet — even Interchange Capital Partners, LLC, its most concentrated holder, allocates just 0.1% of its own portfolio to it.

Wilmington Savings Fund Society, FSB has trimmed its MDCX position for two straight quarters, cutting it by $67.0K while still holding $11.4K.

MDCX is up 0.6% today, but institutions show net selling of $5.1M this quarter — a divergence between today's price move and the underlying institutional flow.

MDCX reported a net loss of $47.3M in its latest fiscal year.

• Not yet profitable — net loss of $47.3M in the latest fiscal year
• Net income declined year over year, from -$11.2M to -$47.3M
• Operating cash flow was negative, using $22.8M in cash
• Current ratio of 1.00x — below the conventional 1.5x liquidity buffer
• Total liabilities currently exceed total assets (negative shareholder equity)